The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients

BACKGROUND: Previous studies have shown that Trimetazidine (TMZ) improves vascular endothelial function and reduces the inflammatory process progression. However, limited data have been available regarding its effects on myocardial fibrosis following ischemia and causing left ventricular dysfunction...

Descripción completa

Detalles Bibliográficos
Autores principales: El-khodary, Noha M., Ghoneim, Asser I., El-tayaar, Ahmed A., El-touny, Eman M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516770/
https://www.ncbi.nlm.nih.gov/pubmed/35538296
http://dx.doi.org/10.1007/s10557-022-07340-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516770/
https://www.ncbi.nlm.nih.gov/pubmed/35538296
http://dx.doi.org/10.1007/s10557-022-07340-0

Ejemplares similares